Prelude Therapeutics (PRLD) Stock Chart & Stock Price History $0.74 +0.06 (+8.19%) Closing price 04:00 PM EasternExtended Trading$0.78 +0.04 (+4.73%) As of 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Prelude Therapeutics Stock Price Performance 5 Day Performance-6.85%1 Month Performance-37.48%3 Month Performance-26.95%6 Month Performance-86.60%Year-To-Date Performance-45.57%1 Year Performance-83.67% Receive PRLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address PRLD Stock Chart for Tuesday, March, 4, 2025 PRLD Chart by TradingView Prelude Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/03/2025$0.76$0.68-9.88%$0.77$0.67254,457 shs$37.64 million02/28/2025$0.75$0.76+1.88%$0.78$0.73174,744 shs$41.77 million02/27/2025$0.81$0.75-7.84%$0.83$0.74243,635 shs$41.00 million02/26/2025$0.81$0.81+0.30%$0.84$0.81146,825 shs$44.49 million02/25/2025$0.83$0.81-3.22%$0.85$0.81183,642 shs$44.36 million02/24/2025$0.87$0.83-4.37%$0.91$0.83100,308 shs$45.83 million02/21/2025$0.90$0.87-3.50%$0.93$0.87161,152 shs$47.93 million02/20/2025$0.90$0.90+0.28%$0.95$0.87167,023 shs$49.67 million02/19/2025$0.95$0.90-5.14%$0.98$0.89183,009 shs$49.53 million02/18/2025$0.97$0.95-2.19%$0.99$0.93202,720 shs$52.21 million Get the Latest News and Ratings for PRLD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/17/2025$0.97$0.97$1.01$0.94169,677 shs$53.38 million02/14/2025$0.95$0.97+2.11%$1.01$0.94169,677 shs$53.38 million02/13/2025$0.91$0.95+4.86%$0.96$0.91148,455 shs$52.28 million02/12/2025$0.92$0.91-1.53%$0.97$0.90207,053 shs$49.86 million02/11/2025$1.09$0.92-15.59%$1.08$0.92283,814 shs$50.63 million02/10/2025$1.01$1.09+7.92%$1.09$0.98691,027 shs$59.98 million02/07/2025$1.11$1.01-9.01%$1.13$1.00262,844 shs$55.58 million02/06/2025$1.17$1.11-5.13%$1.19$1.10106,198 shs$61.08 million02/05/2025$1.11$1.17+5.41%$1.19$1.10218,941 shs$64.39 million02/04/2025$1.11$1.11$1.14$1.0974,517 shs$61.08 million02/03/2025$1.10$1.11+0.91%$1.13$1.0765,165 shs$61.08 million Related Companies Genfit Stock Price Chart Pliant Therapeutics Stock Price Chart Compugen Stock Price Chart CARGO Therapeutics Stock Price Chart Ocugen Stock Price Chart Inhibikase Therapeutics Stock Price Chart Enanta Pharmaceuticals Stock Price Chart Inhibrx Stock Price Chart INmune Bio Stock Price Chart Nanobiotix Stock Price Chart Receive PRLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRLD) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prelude Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Prelude Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRLD Stock Alerts